Form 4 for BAX Baxter International

Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001062993-23-021913 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2023-12-05	2023-12-01	BAX	Grade Joel T.	EVP, CFO	A - Grant	$0.00	+53.2K	53.2K	New	$0
D	2023-12-05	2023-12-01	BAX	Grade Joel T.	EVP, CFO	A - Grant	$0.00	+102.3K	102.3K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, $1 par value	2023-12-01	A	A	27,988	$0.00	27,988	D	—	—	(F1) The reporting person received a restricted stock unit grant which is scheduled to vest in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
2	Common	Common Stock, $1 par value	2023-12-01	A	A	25,189	$0.00	53,177	D	—	—	(F2) The reporting person received a restricted stock unit grant which is scheduled to vest in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
3	Derivative	Stock Option (Right to Buy)	2023-12-01	A	A	102,273	$0.00	102,273	D	$36.55 · — to 2033-12-01	102,273 Common Stock, $1 par value	(F3) The options become exercisable in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date.